Literature DB >> 19927349

Rapid liquid chromatography/tandem mass spectrometer (LCMS) method for clozapine and its metabolite N-desmethyl clozapine (norclozapine) in human serum.

L V Rao1, M L Snyder, G M Vallaro.   

Abstract

Clozapine is indicated for the treatment of schizophrenia and related psychotic disorders. Several methods have been developed for monitoring Clozapine levels; however, they possess limited specificity and are often laborious. This study describes a simple liquid chromatography/tandem mass spectrometer (LCMS) method in human serum. The ion transitions monitored were m/z 327, 270, 296 for Clozapine, m/z 313, 192, 227 for Norclozapine and m/z 328, 271 for Loxapine. The assay is linear (25-1000 ng/ml) and showed a good correlation (r=0.98) within the analytical range of 79-1210 ng/ml in human serum. This assay is highly specific and sensitive for the simultaneous measurements of Clozapine and Norclozapine. The simplification of this assay makes it ideal for high throughput analyses of the patient samples in a routine clinical laboratory staffed with general medical technologists.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19927349      PMCID: PMC6649014          DOI: 10.1002/jcla.20345

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  37 in total

1.  High throughput therapeutic drug monitoring of clozapine and metabolites in serum by on-line coupling of solid phase extraction with liquid chromatography-mass spectrometry.

Authors:  H A G Niederländer; E H M Koster; M J Hilhorst; H J Metting; M Eilders; B Ooms; G J de Jong
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-03-09       Impact factor: 3.205

2.  Determination of clozapine and its major metabolites in human plasma and red blood cells by high-performance liquid chromatography with ultraviolet absorbance detection.

Authors:  C Guitton; J M Kinowski; R Aznar; F Bressolle
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1997-03-07

3.  Effect of post-mortem changes on peripheral and central whole blood and tissue clozapine and norclozapine concentrations in the domestic pig (Sus scrofa).

Authors:  R J Flanagan; A Amin; W Seinen
Journal:  Forensic Sci Int       Date:  2003-03-12       Impact factor: 2.395

4.  Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients.

Authors:  M Aravagiri; S R Marder
Journal:  J Pharm Biomed Anal       Date:  2001-09       Impact factor: 3.935

5.  Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detection.

Authors:  U Bondesson; L H Lindström
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Relation of blood counts during clozapine treatment to serum concentrations of clozapine and nor-clozapine.

Authors:  L Kola Oyewumi; Zack Z Cernovsky; David J Freeman; David L Streiner
Journal:  Can J Psychiatry       Date:  2002-04       Impact factor: 4.356

7.  [Determination of clozapine and its N-demethylated metabolite in serum by gas chromatography-mass spectrometry with selected ion monitoring].

Authors:  R Zhu; C Wang; J Zhao; Y Chen; H Zhou
Journal:  Se Pu       Date:  1998-07

8.  [The determination of clozapine in blood and urine by gas chromatography-mass spectrometry].

Authors:  A B Melent'ev; I V Kurochkina
Journal:  Sud Med Ekspert       Date:  1999 Jul-Aug

9.  Serum concentrations of clozapine determined by nitrogen selective gas chromatography.

Authors:  R Heipertz; H Pilz; W Beckers
Journal:  Arch Toxicol       Date:  1977-08-09       Impact factor: 5.153

10.  Column liquid chromatographic determination of clozapine and N-desmethylclozapine in human serum using solid-phase extraction.

Authors:  R N Gupta
Journal:  J Chromatogr B Biomed Appl       Date:  1995-11-17
View more
  2 in total

1.  Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis.

Authors:  Laura K Green; Pirooz Zareie; Nikki Templeton; Robert A Keyzers; Bronwen Connor; Anne Camille La Flamme
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-03-17

2.  Localisation of clozapine during experimental autoimmune encephalomyelitis and its impact on dopamine and its receptors.

Authors:  Katharina Robichon; Sven Sondhauss; T William Jordan; Robert A Keyzers; Bronwen Connor; Anne C La Flamme
Journal:  Sci Rep       Date:  2021-02-03       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.